{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:39:02Z","timestamp":1761561542403},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2011]]},"DOI":"10.5551\/jat.6981","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T11:22:51Z","timestamp":1308136971000},"page":"298-304","source":"Crossref","is-referenced-by-count":23,"title":["Endothelial Dysfunction in Paroxysmal Atrial Fibrillation as a Prothrombotic State"],"prefix":"10.5551","volume":"18","author":[{"given":"Yuya","family":"Matsue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Seya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Iwatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentarou","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Kumasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Nagahori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991; 22: 983-988","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mitusch R, Siemens HJ, Garbe M, Wagner T, Sheikhzadeh A, Diederich KW: Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost, 1996; 75: 219-223","DOI":"10.1055\/s-0038-1650247"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lip GY, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG: Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation, 1996; 94: 425-431","DOI":"10.1161\/01.CIR.94.3.425"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J: Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke, 1990; 21: 47-51","DOI":"10.1161\/01.STR.21.1.47"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.73.6.527"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, Hori M: Plasma levels of nitrite\/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol, 1997; 17: 3191-3195","DOI":"10.1161\/01.ATV.17.11.3191"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2001.22107"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL: ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006; 114: e257-e354","DOI":"10.1161\/CIRCULATIONAHA.106.177292"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00489-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med, 1990; 323: 1505-1511","DOI":"10.1056\/NEJM199011293232201"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2531"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00427-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK: Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost, 1993; 70: 380-385","DOI":"10.1055\/s-0038-1649589"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1194"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Folsom AR, Conlan MG, Davis CE, Wu KK: Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol, 1992; 2: 481-494","DOI":"10.1016\/1047-2797(92)90098-B"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo Bon G: Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation, 1998; 97: 953-957","DOI":"10.1161\/01.CIR.97.10.953"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00749-2"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.813311"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000164260.82417.3F"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3848"},{"key":"21","unstructured":"21) Thibault B, Talajic M, Dubuc M, Guerra P, Gagne P, Roy D, Connolly S; Canadian Trial of Atrial Fibrillation: Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience. Can J Cardiol, 2004; 20: 195-199"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dhindsa M, Sommerlad SM, DeVan AE, Barnes JN, Sugawara J, Ley O, Tanaka H: Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol, 2008; 105: 427-432","DOI":"10.1152\/japplphysiol.90431.2008"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00329-2"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-007-9141-4"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn101"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60443-8"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.070"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.063"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT: Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest, 2005; 128: 3421-3427","DOI":"10.1378\/chest.128.5.3421"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:11:27Z","timestamp":1637820687000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/18\/4\/18_6981\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.6981","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}